These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8162986

  • 1. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
    Dahlén B, Zetterström O, Björck T, Dahlén SE.
    Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986
    [Abstract] [Full Text] [Related]

  • 2. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
    Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT.
    Lancet; 1991 Mar 23; 337(8743):690-4. PubMed ID: 1672176
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ, Glass M, Minkwitz MC.
    Clin Pharmacol Ther; 1993 Oct 23; 54(4):430-6. PubMed ID: 8222486
    [Abstract] [Full Text] [Related]

  • 4. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT.
    Am Rev Respir Dis; 1993 Jun 23; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [Abstract] [Full Text] [Related]

  • 5. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
    Dahlén B, Kumlin M, Margolskee DJ, Larsson C, Blomqvist H, Williams VC, Zetterström O, Dahlén SE.
    Eur Respir J; 1993 Jul 23; 6(7):1018-26. PubMed ID: 8396534
    [Abstract] [Full Text] [Related]

  • 6. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
    Findlay SR, Barden JM, Easley CB, Glass M.
    J Allergy Clin Immunol; 1992 May 23; 89(5):1040-5. PubMed ID: 1583246
    [Abstract] [Full Text] [Related]

  • 7. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma.
    Nathan RA, Glass M, Minkwitz MC.
    Chest; 1994 Feb 23; 105(2):483-8. PubMed ID: 8306751
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL, Watson RM, Wyile G, O'Byrne PM.
    Thorax; 1997 Apr 23; 52(4):348-54. PubMed ID: 9196518
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M, Dahlén B, Björck T, Zetterström O, Granström E, Dahlén SE.
    Am Rev Respir Dis; 1992 Jul 23; 146(1):96-103. PubMed ID: 1320824
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
    Smith LJ, Geller S, Ebright L, Glass M, Thyrum PT.
    Am Rev Respir Dis; 1990 Apr 23; 141(4 Pt 1):988-92. PubMed ID: 2158260
    [Abstract] [Full Text] [Related]

  • 11. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V, Van De Velde V, Pauwels R, Joos G.
    Pulm Pharmacol Ther; 2008 Apr 23; 21(2):276-84. PubMed ID: 17611132
    [Abstract] [Full Text] [Related]

  • 12. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z, Timmers MC, van der Veen H, Friedman BS, De Smet M, Depré M, Hilliard D, Bel EH, Sterk PJ.
    J Allergy Clin Immunol; 1995 Jan 23; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [Abstract] [Full Text] [Related]

  • 13. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE.
    Am J Respir Crit Care Med; 1998 Apr 23; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [Abstract] [Full Text] [Related]

  • 14. Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects.
    Mulder A, Gauvreau GM, Watson RM, O'byrne PM.
    Am J Respir Crit Care Med; 1999 May 23; 159(5 Pt 1):1562-7. PubMed ID: 10228127
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
    Dahlén B, Kumlin M, Ihre E, Zetterström O, Dahlén SE.
    Thorax; 1997 Apr 23; 52(4):342-7. PubMed ID: 9196517
    [Abstract] [Full Text] [Related]

  • 16. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC, Georgiou P, Howland K, Dennis M, Compton CH, Barnes NC.
    Thorax; 1997 Jun 23; 52(6):519-22. PubMed ID: 9227717
    [Abstract] [Full Text] [Related]

  • 17. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK, Lau LC, Thomson HW, Binks SM, Holgate ST.
    Am Rev Respir Dis; 1993 Jun 23; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [Abstract] [Full Text] [Related]

  • 18. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.
    Roquet A, Dahlén B, Kumlin M, Ihre E, Anstrén G, Binks S, Dahlén SE.
    Am J Respir Crit Care Med; 1997 Jun 23; 155(6):1856-63. PubMed ID: 9196086
    [Abstract] [Full Text] [Related]

  • 19. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
    Frølund L, Madsen F, Nielsen J.
    Allergy; 1991 Jul 23; 46(5):355-61. PubMed ID: 1928658
    [Abstract] [Full Text] [Related]

  • 20. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ, Barnes PJ, Spaethe SM, van Alstyne EL, Mitchell MI, O'Connor BJ.
    Thorax; 1996 Dec 23; 51(12):1178-84. PubMed ID: 8994512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.